IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Immatics N.V.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$7.05+0.32 (+4.75%)
Close on Oct 19, 2026
Share price
−$2.82 (−28.57%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -1.61 EUR
- Free cash flow
- -€183.18M
Valuation needs the share price. It fills in once daily prices are connected and converted from EUR.
Nine years at a glance
Fiscal years 2017 to 2025, EUR
Operating income
-€182.02M
Net income
–
EPS, diluted
-1.61 EUR-1250.0% YoY
Free cash flow
-€183.18M
Reported period